Simplify Logo

Full-Time

MES Specialist I

Posted on 7/9/2024

ElevateBio

ElevateBio

201-500 employees

Develops and manufactures cell and gene therapies

Biotechnology
Healthcare

Mid

Waltham, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • 2+ years of manufacturing/Tech Ops/MSAT experience
  • Understanding of a manufacturing area of specialization and GMP regulations
  • Experience within cell & gene therapy, biologics, and/or contract manufacturing organizations
  • Previous MES or MOM experience with any platform
  • Experience with MES system administration
  • Experience with using SAP
  • Proficient in Microsoft Office
  • Comfortable delivering trainings and presentations
  • Ability to explain technical topics
  • Ability to work independently and proactively
  • Problem-solving skills
  • Strong communication and collaboration skills
Responsibilities
  • Creating and updating recipes/batch templates
  • Collaborating with various departments
  • Authoring, executing, reviewing, and approving validation testing
  • Participating in on-call rotation
  • Providing basic LIMS support
  • Understanding recipes and process documents
  • Creating training content and facilitating sessions
  • Communicating and collaborating with team members

ElevateBio focuses on biotechnology, specifically in the cell and gene therapy market. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies. Their integrated ecosystem allows them to support the entire process from discovery to commercialization, setting them apart from competitors. The goal is to advance scientific breakthroughs and deliver a wide range of effective therapies.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

24%

1 year growth

19%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • ElevateBio's recent $401 million Series D financing round, led by prominent investors, positions the company for accelerated growth and innovation.
  • The collaboration with the University of Pittsburgh to build the BioForge facility will significantly expand their manufacturing capabilities and technological infrastructure.
  • Their partnerships and commercialization efforts, including potential earnouts up to $2.35 billion with Novo Nordisk, offer substantial financial and developmental opportunities.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation and investment to maintain a leading position.
  • Dependence on strategic partnerships and collaborations may pose risks if these relationships encounter challenges or fail to deliver expected outcomes.

What makes ElevateBio unique

  • ElevateBio's integrated ecosystem of technologies and capabilities allows them to discover, develop, manufacture, and commercialize a broad spectrum of cell and gene therapies, setting them apart from competitors who may only focus on one aspect of the process.
  • Their strategic partnerships with industry leaders like Novo Nordisk and Kyverna Therapeutics enhance their technological and therapeutic development capabilities.
  • The company's proprietary technologies, such as gene editing and induced pluripotent stem cell (iPSC) platforms, provide a competitive edge in the biotechnology market.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE